Q Line Biotech Ltd vs Sylph Industries Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Q-Line Biotech Ltd is ₹ 529.55 as of 23 Oct 15:30 . The P/E Ratio of Q-Line Biotech Ltd changed from 0 on March 2025 to 0 on March 2024 . This represents a CAGR of 0.0% over 4 yearsThe P/E Ratio of Sylph Industries Ltd changed from 11.2 on March 2026 to 0 on March 2024 . This represents a CAGR of -100.00% over 3 years The Market Cap of Q-Line Biotech Ltd changed from ₹ 0 crore on March 2025 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 4 yearsThe Market Cap of Sylph Industries Ltd changed from ₹ 35.51 crore on March 2025 to ₹ 0 crore on March 2024 . This represents a CAGR of -100.00% over 4 years The revenue of Q-Line Biotech Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 110.94 crore. This represent the decline of -100% The revenue of Sylph Industries Ltd for the Jun '26 is ₹ 6.18 crore as compare to the Mar '26 revenue of ₹ 25.78 crore. This represent the decline of -76.03% The ebitda of Q-Line Biotech Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 33.57 crore. This represent the decline of -100% The ebitda of Sylph Industries Ltd for the Jun '26 is ₹ 0.39 crore as compare to the Mar '26 ebitda of ₹ 1.26 crore. This represent the decline of -69.05% The net profit of Q-Line Biotech Ltd changed from ₹ 17.38 crore to ₹ 0 crore over 3 quarters. This represents a CAGR of -100.00% The net profit of Sylph Industries Ltd changed from ₹ 0.52 crore to ₹ 0.39 crore over 9 quarters. This represents a CAGR of -12.00% The Dividend Payout of Q-Line Biotech Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Sylph Industries Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Q-Line Biotech Ltd

Q-Line Biotech Limited was originally incorporated as 'POCT Services Private Limited' on November 10, 2010 as a Private limited company dated November 10, 2010 issued by the Assistant Registrar of Companies, Uttar Pradesh and Uttarakhand.
Subsequently, the name of Company was changed to 'Q-Line Biotech Private Limited on July 23, 2021.
Further, Company was converted from a private company to public company and the name of Company was changed to 'Q-Line Biotech Limited', via fresh certificate of incorporation dated March 08, 2025 issued by Central Processing Centre. The Company is engaged in the business of developing, manufacturing and marketing of diverse range of reagents (including kits and POC devices) & consumables and manufacturing, importing, distribution/supply of diagnostic equipment for different diagnostic healthcare needs.

About Sylph Industries Ltd

Sylph Technologies Limited was incorporated in May, 1992.
Sylph is a leading software technology company in India, providing software development services & solutions with services such as Outsourcing Software Development, Web Development, Product Development, Strategy Consulting, Offshore Software Development, E-Commerce for Web and Mobile Enablement.
The Company has also engaged in the distribution of a 25 year old Newspaper. Company operates in four segments namely Information Technology, Education, Printing and Publishing Newspapers and Trading of Solar Power Plant.
The Company started warehousing business and the business of Education through IT during year 2010-11.
In 2015, it launched BPO Service & KPO Service; and later on, started trading of Solar Power Product in 2018. The Company delivers higher value returns through cutting edge expertise and offshore outsourcing and software outsourcing solutions for business and technology requirements.

FAQs for the comparison of Q-Line Biotech Ltd and Sylph Industries Ltd

Which company has a larger market capitalization, Q-Line Biotech Ltd or Sylph Industries Ltd?

Market cap of Q-Line Biotech Ltd is 1,235 Cr while Market cap of Sylph Industries Ltd is 19 Cr

What are the key factors driving the stock performance of Q-Line Biotech Ltd and Sylph Industries Ltd?

The stock performance of Q-Line Biotech Ltd and Sylph Industries Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Q-Line Biotech Ltd and Sylph Industries Ltd?

As of October 25, 2026, the Q-Line Biotech Ltd stock price is INR ₹529.55. On the other hand, Sylph Industries Ltd stock price is INR ₹0.16.

How do dividend payouts of Q-Line Biotech Ltd and Sylph Industries Ltd compare?

To compare the dividend payouts of Q-Line Biotech Ltd and Sylph Industries Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.